2 CONCENTRATIONS OF TOPICAL TRETINOIN (RETINOIC ACID) CAUSE SIMILAR IMPROVEMENT OF PHOTOAGING BUT DIFFERENT DEGREES OF IRRITATION - A DOUBLE-BLIND, VEHICLE-CONTROLLED COMPARISON OF 0.1-PERCENT AND 0.025-PERCENT TRETINOIN CREAMS
Cem. Griffiths et al., 2 CONCENTRATIONS OF TOPICAL TRETINOIN (RETINOIC ACID) CAUSE SIMILAR IMPROVEMENT OF PHOTOAGING BUT DIFFERENT DEGREES OF IRRITATION - A DOUBLE-BLIND, VEHICLE-CONTROLLED COMPARISON OF 0.1-PERCENT AND 0.025-PERCENT TRETINOIN CREAMS, Archives of dermatology, 131(9), 1995, pp. 1037-1044
Background and Design: The efficacy of topical tretinoin (all-tuans-re
tinoic acid) in treating photoaging is well established. Questions tha
t remain are (1) whether irritation causes all or part of the improvem
ent; (2) the concentration of tretinoin that maximizes clinical respon
se with minimal side effects; and (3) the effects of longterm treatmen
t on components of the cutaneous immune system. To address these issue
s, 99 photoaged patients completed a 48-week study using 0.1% tretinoi
n cream (n=32), 0.025% tretinoin (n=35), or vehicle (n=32) once daily
in a double-blind manner. Before and after treatment, we assessed hist
ologic features, keratinocyte expression of HLA-DR and intercellular a
dhesion molecule-1, numbers of epidermal Langerhans' cells and epiderm
al and dermal T lymphocytes, and vascularity as measured by dermal end
othelial cell area. Results: Both 0.1% and 0.025% tretinoin produced s
tatistically significant overall improvement in photoaging of the face
compared with vehicle; there were no clinically or statistically sign
ificant differences in efficacy between the two concentrations of tret
inoin. After 48 weeks, 0.1% and 0.025% tretinoin produced similar stat
istically significant epidermal thickening (by 30% and 28%, respective
ly) compared with vehicle (11% decrease) and increased vascularity (by
100% and 89%, respectively) compared with vehicle (9% decrease). By v
arious analyses, irritant side effects (erythema and scaling) were sta
tistically significantly greater with 0.1% tretinoin than with 0.025%
tretinoin. No significant changes occurred in any immunologic markers
when tretinoin and vehicle treatments were compared. Conclusions: Tret
inoin 0.1% and 0.025% produce similar clinical and histologic changes
in patients with photoaging, despite significantly greater incidence o
f irritation with the higher concentration. The separation between cli
nical improvement and irritation suggests that mechanisms other than i
rritation dominate tretinoininduced repair of photoaging in humans.